logo

For the Inventor, By the Inventor

Oakland, CA, United States of America

Adam Renslo

This inventor holds 31 USPTO granted patents, primarily in Pharmaceutical Innovations. Top assignees: University of California, University of South Florida, Pharmacia & Upjohn Company. Active years: 2005-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adam Renslo. Retrieved from https://idiyas.com/inventor/adam-renslo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31

% Patents Active = 61.3

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 68(Granted Patents)


Location History:

  • San Francisco, CA (US) (2020)
  • Oakland, CA (US) (2005 - 2023)

Company Filing History:

goldMedal24 out of 16,035 
 
University of California
 patents
silverMedal5 out of 1,993 
 
University of South Florida
 patents
bronzeMedal4 out of 523 
 
Pharmacia & Upjohn Company
 patents
4. 3 out of 4 
 
Leidos Biomedical Research, Inc.
 patents
5. 3 out of 4,488 
 
Pfizer Corporation
 patents
6. 1 out of 1 
 
Advanced Genetic Systems, Inc.
 patent
where one patent can have more than one assignee

Years Active: 2005-2024

Loading Chart...
Areas of Expertise:
K-Ras Modulators
Beta-Lactamase Inhibitors
Prodrug Compositions
Cyclic Peroxides
Small-Molecule Inhibitors
Antimicrobial Compounds
eIF2alpha Pathway
Oxazolidinone Derivatives
HIV Treatment
Cancer Therapy
Malaria Treatment
Androgen Receptor
31 patents (USPTO):Explore Patents
1. 12139470 - Trioxolane agents (2024-11-12),
2. 11541044 - K-Ras modulators (2023-01-03),
3. 11358940 - K-Ras modulators (2022-06-14),
4. 11220477 - Modulators of the eIF2alpha pathway (2022-01-11),
5. 11072594 - Trioxolane agents (2021-07-27),
6. 11014955 - Cyclic peroxides as prodrugs for selective delivery of agents (2021-05-25),
7. 10864222 - Beta-lactamase inhibitors, formulations, and uses thereof (2020-12-15),
8. 10857140 - K-Ras modulators (2020-12-08),
9. 10688080 - Compositions, methods of use, and methods of treatment (2020-06-23),
10. 10662215 - Cyclic peroxides as prodrugs for selective delivery of agents (2020-05-26),
11. 10604493 - Compositions, methods of use, and methods of treatment (2020-03-31),
12. 10543221 - Beta-lactamase inhibitors, formulations, and uses thereof (2020-01-28),
13. 10343981 - Modulators of the eIF2alpha pathway (2019-07-09),
14. 10287312 - Cyclic peroxides as prodrugs for selective delivery of agents (2019-05-14),
15. 10154992 - Compounds and methods for treating HIV infection (2018-12-18),

Title: Adam Renslo: Innovator and Researcher in Disease Treatment

Introduction

Adam Renslo, based in Oakland, CA, is a distinguished inventor and researcher with an impressive portfolio of 31 patents. His work focuses primarily on innovative compounds and methods aimed at treating and detecting various diseases, particularly in the realm of cancer research.

Latest Patents

Among Adam's latest groundbreaking patents are trioxolane agents, which disclose trioxolane compounds and methods for their application in treating and detecting diseases. Additionally, he has developed K-Ras modulators that provide novel methods and compounds for inhibiting K-Ras, a crucial focus in cancer therapy.

Career Highlights

Adam has made significant contributions to the field of biomedical research, having worked with notable institutions such as the University of California and the University of South Florida. His role in these institutions has facilitated pivotal advancements in the development of therapeutic agents aimed at combating serious health conditions.

Collaborations

Throughout his career, Adam Renslo has collaborated with esteemed colleagues, including Gary W. Luehr and Erica M. W. Lauterwasser. These partnerships have fostered a dynamic environment for innovation and research, enhancing the impact of their work on the medical community.

Conclusion

With his extensive portfolio of patents and collaborative efforts in research, Adam Renslo continues to be a vital figure in the field of medical innovation. His dedication to improving disease treatment and diagnosis paves the way for future advancements that hold the promise of better health outcomes for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…